Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.

Blasio A, Iemolo A, Sabino V, Petrosino S, Steardo L, Rice KC, Orlando P, Iannotti FA, Di Marzo V, Zorrilla EP, Cottone P.

Neuropsychopharmacology. 2013 Nov;38(12):2498-507. doi: 10.1038/npp.2013.153. Epub 2013 Jun 24.

2.
3.

The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.

Dore R, Valenza M, Wang X, Rice KC, Sabino V, Cottone P.

Addict Biol. 2014 Sep;19(5):849-61. doi: 10.1111/adb.12056. Epub 2013 Apr 16.

4.

CRF-CRF1 receptor system in the central and basolateral nuclei of the amygdala differentially mediates excessive eating of palatable food.

Iemolo A, Blasio A, St Cyr SA, Jiang F, Rice KC, Sabino V, Cottone P.

Neuropsychopharmacology. 2013 Nov;38(12):2456-66. doi: 10.1038/npp.2013.147. Epub 2013 Jun 10.

6.

CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.

Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA.

Neuropharmacology. 2008 May;54(6):976-88. doi: 10.1016/j.neuropharm.2008.02.005. Epub 2008 Feb 16.

PMID:
18371990
7.

Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.

Gamble-George JC, Conger JR, Hartley ND, Gupta P, Sumislawski JJ, Patel S.

Psychopharmacology (Berl). 2013 Aug;228(3):401-9. doi: 10.1007/s00213-013-3042-8. Epub 2013 Mar 13.

8.

Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses.

Parylak SL, Cottone P, Sabino V, Rice KC, Zorrilla EP.

Physiol Behav. 2012 Sep 10;107(2):231-42. doi: 10.1016/j.physbeh.2012.06.017. Epub 2012 Jul 6.

9.

Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.

Scherma M, Fattore L, Satta V, Businco F, Pigliacampo B, Goldberg SR, Dessi C, Fratta W, Fadda P.

Br J Pharmacol. 2013 Jun;169(4):820-33. doi: 10.1111/bph.12014.

10.

The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.

Gueye AB, Pryslawsky Y, Trigo JM, Poulia N, Delis F, Antoniou K, Loureiro M, Laviolette SR, Vemuri K, Makriyannis A, Le Foll B.

Int J Neuropsychopharmacol. 2016 Dec 30;19(12). pii: pyw068. doi: 10.1093/ijnp/pyw068. Print 2016 Dec.

11.

Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant.

Martín-García E, Burokas A, Martín M, Berrendero F, Rubí B, Kiesselbach C, Heyne A, Gispert JD, Millán O, Maldonado R.

J Neurochem. 2010 Mar;112(5):1338-13351. doi: 10.1111/j.1471-4159.2009.06549.x. Epub 2009 Dec 17.

12.

Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.

Pavón FJ, Serrano A, Pérez-Valero V, Jagerovic N, Hernández-Folgado L, Bermúdez-Silva FJ, Macías M, Goya P, de Fonseca FR.

J Neuroendocrinol. 2008 May;20 Suppl 1:116-23. doi: 10.1111/j.1365-2826.2008.01693.x. Review.

PMID:
18426510
13.

Withdrawal from chronic, intermittent access to a highly palatable food induces depressive-like behavior in compulsive eating rats.

Iemolo A, Valenza M, Tozier L, Knapp CM, Kornetsky C, Steardo L, Sabino V, Cottone P.

Behav Pharmacol. 2012 Sep;23(5-6):593-602. doi: 10.1097/FBP.0b013e328357697f.

14.

Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.

Rorato R, Reis WL, de Carvalho Borges B, Antunes-Rodrigues J, Elias LL.

Neuropharmacology. 2012 Jul;63(1):154-60. doi: 10.1016/j.neuropharm.2011.11.009. Epub 2011 Nov 27.

PMID:
22138163
15.

Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.

Deshmukh RR, Sharma PL.

Pharmacol Res. 2012 Sep;66(3):276-82. doi: 10.1016/j.phrs.2012.06.004. Epub 2012 Jun 21.

PMID:
22728691
17.

Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.

González S, Fernández-Ruiz J, Di Marzo V, Hernández M, Arévalo C, Nicanor C, Cascio MG, Ambrosio E, Ramos JA.

Drug Alcohol Depend. 2004 May 10;74(2):159-70.

PMID:
15099659
18.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
19.

Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.

Wakley AA, Rasmussen EB.

Pharmacol Biochem Behav. 2009 Nov;94(1):30-6. doi: 10.1016/j.pbb.2009.07.002. Epub 2009 Jul 12.

PMID:
19602424
20.

Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats.

DiPatrizio NV, Simansky KJ.

J Neurosci. 2008 Sep 24;28(39):9702-9. doi: 10.1523/JNEUROSCI.1171-08.2008.

Supplemental Content

Support Center